NCT07891741 Study of 3D Ultrasound for Support of Hemodialysis Cannulation
| NCT ID | NCT07891741 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sonavex, Inc. |
| Condition | Dialysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-07 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-05-07 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, single arm, multi-center two-stage feasibility study designed to evaluate the safety and effectiveness of the use of the EchoMap device to assist in traditional methods of AV fistula cannulation.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years but \< 85 years of age at the time of informed consent * Subjects who have received an upper extremity autologous arteriovenous fistula, which has been cleared for at least 1-needle cannulation * Subjects have a fistula with a history of miscannulation or requires an expert cannulator or have a new fistula that has not previously been cannulated * Subject is able to sign informed consent and able to participate in all testing associated with this clinical investigation Exclusion Criteria: * Age \<18 years old * Subject unable to sign informed consent. * Subject is breastfeeding, pregnant, or plans to become pregnant * Prisoner or Subject from vulnerable populations as defined in 45 CFR 46. * Subjects that do not have a clinically mature upper extremity AV fistula that is cleared for at least 1-needle cannulation * Subjects that do not have a fistula with a history of miscannulation or requires an expert cannulator or do not have a new fistula that has not previously been cannulated * Subjects that are cannulated through a buttonhole technique * Subjects with a history of poor compliance with the dialysis protocol * Subjects who have suffered an access related injury or underwent access related intervention in the last 2 weeks
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07891741 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Dialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07891741 currently recruiting?
Yes, NCT07891741 is actively recruiting participants. Contact the research team at rdelnegro@sonavex.com for enrollment information.
Where is the NCT07891741 trial being conducted?
This trial is being conducted at Hartford, United States, Middlebury, United States, Greenville, United States.
Who is sponsoring the NCT07891741 clinical trial?
NCT07891741 is sponsored by Sonavex, Inc.. The trial plans to enroll 20 participants.